Jointly provided by the Crohn's & Colitis Foundation, RMEI Medical Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by independent educational grants from AbbVie and Salix Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America LLC.
Target Audience: This activity is intended for gastroenterologists, gastroenterology nurse practitioners, and PAs who actively manage patients with inflammatory bowel disease (IBD), as well as managed care directors and hospital pharmacists interested in IBD treatment options.
This series consists of six CME activities. The links below will direct learners to activity details and content.
Estimated Time to Complete All Modules: 5 hours and 15 minutes
ACPE release/expiration dates: December 18, 2017/December 18, 2018.